[go: up one dir, main page]

JP2005289953A - ANTIBACTERIAL AGENT COMPRISING METHYL p-HYDROXYBENZOATE AS ACTIVE INGREDIENT AND EXTERNAL COMPOSITION COMPRISING THE SAME - Google Patents

ANTIBACTERIAL AGENT COMPRISING METHYL p-HYDROXYBENZOATE AS ACTIVE INGREDIENT AND EXTERNAL COMPOSITION COMPRISING THE SAME Download PDF

Info

Publication number
JP2005289953A
JP2005289953A JP2004134805A JP2004134805A JP2005289953A JP 2005289953 A JP2005289953 A JP 2005289953A JP 2004134805 A JP2004134805 A JP 2004134805A JP 2004134805 A JP2004134805 A JP 2004134805A JP 2005289953 A JP2005289953 A JP 2005289953A
Authority
JP
Japan
Prior art keywords
antibacterial agent
corynebacterium
antibacterial
methyl
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004134805A
Other languages
Japanese (ja)
Inventor
Katsuya Shimoo
克也 下尾
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kobayashi Pharmaceutical Co Ltd
Original Assignee
Kobayashi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobayashi Pharmaceutical Co Ltd filed Critical Kobayashi Pharmaceutical Co Ltd
Priority to JP2004134805A priority Critical patent/JP2005289953A/en
Priority to PCT/JP2004/013899 priority patent/WO2005099683A1/en
Publication of JP2005289953A publication Critical patent/JP2005289953A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To obtain an antibacterial agent having excellent antibacterial actions on bacteria of Corynebacterium sp. considered as a cause of a body odor (osmidrosis axillae) and to obtain an external composition comprising the antibacterial agent. <P>SOLUTION: The antibacterial agent against the bacteria of the Corynebacterium sp. comprises methyl p-hydroxybenzoate as an active ingredient. The external composition comprises the antibacterial agent. <P>COPYRIGHT: (C)2006,JPO&NCIPI

Description

本発明は、パラオキシ安息香酸メチルを有効成分とする抗菌剤、及び該抗菌剤を含有する外用組成物に関する。  The present invention relates to an antibacterial agent containing methyl paraoxybenzoate as an active ingredient and a composition for external use containing the antibacterial agent.

発汗に伴う不快臭は、本来は無臭かつ無菌である汗が皮表の微生物によって分解されることによって生じることが知られており、これに皮表や汗中のアンモニアが加わるとさらに特有の臭気となる。とりわけ体臭の中でも鼻をつくような独特な臭いである腋臭は、腋窩部のアポクリン汗腺から分泌されるアポクリン汗が皮表に存在するコリネバクテリウム属菌や表皮ブドウ球菌(これらの一定のバランスを保って皮膚に定着している細菌の集まりを、皮膚細菌叢と呼ぶ)によって分解されることで発生する(例えば非特許文献1参照)これらの皮膚細菌叢のうち、腋臭に直接関連する微生物は、コリネバクテリウム属菌であることが知られている。  The unpleasant odor associated with sweating is known to be caused by the decomposition of the odorless and sterile sweat by microorganisms on the skin surface. When ammonia in the skin surface or sweat is added to this, a more specific odor is generated. It becomes. In particular, the vomiting odor, which is a peculiar odor of body odor, has a certain balance between corynebacterium sp. And epidermis staphylococci that have apocrine sweat secreted from the apocrine sweat glands in the axilla. A group of bacteria that are kept and fixed on the skin is referred to as skin flora) (see, for example, Non-Patent Document 1) Among these skin flora, It is known to be a genus Corynebacterium.

従来、体臭の発生を抑制するために、発汗防止剤、制汗収斂剤、抗生物質または抗菌剤などが使用されている。しかしながら、発汗防止剤や制汗収斂剤は汗の分泌量の多い人には余り効果がなく、特にヒドロキシ塩化アルミニウム(アルミニウム塩化水和物)のようなアルミニウム塩からなる制汗収斂剤はそのタンパク質変性作用のため皮膚への刺激性が強いという問題がある。また、塩化ベンゼトニウムや塩化ベンザルコニウムなどの抗菌剤や抗生物質は、効果は高いものの、体臭の原因となる微生物だけでなく皮膚細菌叢を形成する微生物までも殺菌若しくは静菌してしまうため、健全な皮膚細菌叢形成による皮膚本来の自浄作用を損なってしまという危険性を有している。  Conventionally, antiperspirants, antiperspirant astringents, antibiotics or antibacterial agents have been used to suppress the generation of body odor. However, antiperspirants and antiperspirant astringents are not very effective for people with a high amount of sweat, especially antiperspirant astringents made of aluminum salts such as hydroxyaluminum chloride (aluminum chloride hydrate). There is a problem that it is highly irritating to the skin due to its degenerative action. In addition, although antibacterial agents and antibiotics such as benzethonium chloride and benzalkonium chloride are highly effective, not only microorganisms that cause body odor but also microorganisms that form skin flora will be sterilized or bacteriostatic, There is a risk that the skin's original self-cleaning action is impaired due to the formation of healthy skin flora.

そこで、不快な体臭を防止する方法を開発するためには、不快臭を発生する原因のもととなる菌に選択的な殺菌作用を有する抗菌剤を見出すことが必要とされている。
Hurley,H.J.Jr.:Diseases of apocrinesweat glands.Dermatology in General Medecine.p.386,McGraw−Hill,New York(1971)
Therefore, in order to develop a method for preventing an unpleasant body odor, it is necessary to find an antibacterial agent having a bactericidal action selective to the bacteria that cause the unpleasant odor.
Hurley, H.C. J. et al. Jr. : Diseases of apocrinesweats grands. Dermatology in General Medine. p. 386, McGraw-Hill, New York (1971)

本発明は、腋臭の原因とされるコリネバクテリウム属菌に対して優れた抗菌作用を有する抗菌剤、及び該抗菌剤を含有する外用組成物を提供することを主な目的とする。  The main object of the present invention is to provide an antibacterial agent having an excellent antibacterial action against Corynebacterium which is a cause of a bad odor, and an external composition containing the antibacterial agent.

本発明者らは、従来、防腐剤として使用されていたパラオキシ安息香酸類のなかでも、特にパラオキシ安息香酸メチルが、コリネバクテリウム属菌に対して優れた抗菌作用を有することを見出し、本発明を完成するに至った。  The present inventors have found that among paraoxybenzoic acids conventionally used as preservatives, methyl paraoxybenzoate has an excellent antibacterial action against Corynebacterium, and the present invention It came to be completed.

本発明は、以下の抗菌剤及び外用組成物を提供する。
項1.パラオキシ安息香酸メチルを有効成分とするコリネバクテリウム属菌に対する抗菌剤。
項2.コリネバクテリウム属菌が、コリネバクテリウム キセロシス、コリネバクテリウム ミヌティシマム又はコリネバクテリウム テヌイスである項1に記載の抗菌剤。
項3.パラオキシ安息香酸メチルを0.2重量%以上含有する項1又は2のいずれかに記載の抗菌剤。
項4.さらに皮膚滞留剤を含有する項1〜3のいずれかに記載の抗菌剤。
項5.該皮膚滞留剤が、プロピレングリコールである項4に記載の抗菌剤。
項6.項1〜5のいずれかに記載の抗菌剤を含有する外用組成物。
項7.腋臭防止用である項6に記載の外用組成物。
The present invention provides the following antibacterial agents and compositions for external use.
Item 1. An antibacterial agent against Corynebacterium which contains methyl paraoxybenzoate as an active ingredient.
Item 2. Item 2. The antibacterial agent according to item 1, wherein the Corynebacterium is Corynebacterium xerosis, Corynebacterium minutishima or Corynebacterium tenuis.
Item 3. Item 3. The antibacterial agent according to any one of Items 1 and 2, which contains 0.2% by weight or more of methyl paraoxybenzoate.
Item 4. Item 4. The antibacterial agent according to any one of Items 1 to 3, further comprising a skin retention agent.
Item 5. Item 5. The antibacterial agent according to Item 4, wherein the skin retention agent is propylene glycol.
Item 6. Item 6. An external composition containing the antibacterial agent according to any one of Items 1 to 5.
Item 7. Item 7. The composition for external use according to Item 6, which is used for preventing odor.

本発明の抗菌剤の有効成分であるパラオキシ安息香酸メチルは、医薬品、医薬部外品、化粧品及び食品の分野で使用されているものを広く使用することができる。パラオキシ安息香酸メチルとしては、塩の形態であってもよく、かかる塩としてはパラオキシ安息香酸メチルナトリウム等のアルカリ金属塩を例示することができる。パラオキシ安息香酸メチルまたはその塩は、1種単独で使用してもまた2種以上を任意に組み合わせて使用することもできる。  As the methyl paraoxybenzoate which is an active ingredient of the antibacterial agent of the present invention, those used in the fields of pharmaceuticals, quasi drugs, cosmetics and foods can be widely used. The methyl paraoxybenzoate may be in the form of a salt, and examples of such a salt include alkali metal salts such as methyl sodium paraoxybenzoate. Methyl paraoxybenzoate or a salt thereof can be used alone or in any combination of two or more.

実施例に示すように、本発明の抗菌剤は、コリネバクテリウム属菌(Corynebacterium sp.)に対して優れた抗菌効果を有することを特徴とする。ここでコリネバクテリウム属菌(Corynebacterium sp.)としては、この属の範疇にあるグラム陽性桿菌であれば特に制限されないが、好ましくは腋臭発生の原因となる菌(以下、本発明において腋臭菌ともいう。)であり、このような腋臭菌としては例えば、コリネバクテリウム ミヌティシマム(Corynebacterium minutissimum)、コリネバクテリウム キセロシス(Corynebacterium xerosis)、又はコリネバクテリウム テヌイス(Corynebacterium tenuis)等が知られている。  As shown in the Examples, the antibacterial agent of the present invention is characterized by having an excellent antibacterial effect against Corynebacterium sp. Here, Corynebacterium sp. Is not particularly limited as long as it is a gram-positive gonococcus in the category of this genus, but is preferably a bacterium that causes generation of odor (hereinafter referred to as odor bacterium in the present invention). Examples of such malodorous bacteria include Corynebacterium minutisium, Corynebacterium xerosis, Corynebacterium tenuis, and the like.

パラオキシ安息香酸メチルを有効成分とする抗菌剤を調製した場合、コリネバクテリウム属菌に対する殺菌作用は、パラオキシ安息香酸メチルの有効量として、0.1重量%程度を越える量、好ましくは0.15重量%程度以上、より好ましくは0.2重量%程度以上である。  When an antibacterial agent containing methyl paraoxybenzoate as an active ingredient is prepared, the bactericidal action against the genus Corynebacterium is an amount exceeding about 0.1% by weight, preferably 0.15, as an effective amount of methyl paraoxybenzoate. It is about wt% or more, more preferably about 0.2 wt% or more.

上記のパラオキシ安息香酸メチルを有効成分とする抗菌剤に、プロピレングリコール、ジプロピレングリコール、1,3−ブチレングリコール等の低揮発性及び低皮膚浸透性の皮膚滞留剤を配合することができる。本発明の抗菌剤と併用する場合、該皮膚滞留剤としては、特にプロピレングリコールが好ましい。これらの皮膚滞留剤を併用することによって、本発明の抗菌剤を皮膚上に滞留させることができ、長時間にわたって抗菌効果を得ることができる。  A low volatility and low skin permeability skin retention agent such as propylene glycol, dipropylene glycol, 1,3-butylene glycol can be blended with the antibacterial agent containing methyl paraoxybenzoate as an active ingredient. When used in combination with the antibacterial agent of the present invention, propylene glycol is particularly preferable as the skin retention agent. By using these skin retention agents in combination, the antibacterial agent of the present invention can be retained on the skin, and an antibacterial effect can be obtained for a long time.

該抗菌剤中の皮膚滞留剤の配合量としては、抗菌作用を発揮するのに充分な時間滞留が可能であり、本発明の効果を妨げない量であれば特に制限されないが、通常、1〜50重量%程度、好ましくは5〜40重量%程度、より好ましくは10〜30重量%程度である。  The blending amount of the skin retention agent in the antibacterial agent is not particularly limited as long as it can be retained for a time sufficient to exert an antibacterial action and does not interfere with the effects of the present invention. About 50% by weight, preferably about 5-40% by weight, more preferably about 10-30% by weight.

さらに、本発明の抗菌剤は、本発明の効果を妨げないことを限度としてパラオキシ安息香酸メチル以外の成分として他の抗菌成分を含有することもできる。かかる抗菌成分としては、具体的にはトリクロサン、トリクロロカルバニリド、塩化ベンザルコニウム、塩化ベンゼトニウム、ハロカルバン、塩酸クロルヘキシジン、ジヒドロファルネソール、イソプロピルメチルフェノール、チモール、ヒノキチオール、塩化セチルピリジニウム、エタノール、イソプロパノール等を例示することができる。本発明抗菌剤にこれらの抗菌成分を含有させた場合、パラオキシ安息香酸メチルは、上記した有効量よりも少ない量で抗菌作用を発揮することが期待できる。したがって、本発明の抗菌剤におけるパラオキシ安息香酸メチルの有効量は、前述する範囲(0.1重量%を超える量)に限定されない。  Furthermore, the antibacterial agent of the present invention can contain other antibacterial components as components other than methyl paraoxybenzoate as long as the effects of the present invention are not hindered. Specific examples of such antibacterial components include triclosan, trichlorocarbanilide, benzalkonium chloride, benzethonium chloride, halocarban, chlorhexidine hydrochloride, dihydrofarnesol, isopropylmethylphenol, thymol, hinokitiol, cetylpyridinium chloride, ethanol, isopropanol, etc. Can be illustrated. When these antibacterial components are contained in the antibacterial agent of the present invention, methyl paraoxybenzoate can be expected to exhibit an antibacterial action in an amount smaller than the above-mentioned effective amount. Therefore, the effective amount of methyl paraoxybenzoate in the antibacterial agent of the present invention is not limited to the above-described range (amount exceeding 0.1% by weight).

本発明の抗菌剤は、皮膚に存在するコリネバクテリウム属菌(Corynebacterium sp.)に対して抗菌作用を有することから、抗菌成分として外用組成物に配合して用いることができる。特に本発明の抗菌剤は、腋臭菌に対して優れた殺菌作用を発揮することから腋臭防止のための外用組成物の抗菌成分として用いることができる。この場合、本発明の抗菌剤の外用組成物への配合割合としては、有効成分であるパラオキシ安息香酸メチルがコリネバクテリウム属菌に対して抗菌効果を発揮する量であればよく、この範囲において特に制限されないが、具体的には該外用組成物中にパラオキシ安息香酸メチルの含有量として0.1重量程度%を超える量、好ましくは0.15重量%程度以上より好ましくは0.2重量%程度以上の範囲で含まれることが望ましい。  Since the antibacterial agent of the present invention has an antibacterial action against Corynebacterium sp. Existing in the skin, it can be used as an antibacterial component in an external composition. In particular, the antibacterial agent of the present invention can be used as an antibacterial component of a composition for external use for preventing a bad smell because it exhibits an excellent bactericidal action against bad smell bacteria. In this case, the proportion of the antibacterial agent of the present invention to the composition for external use may be an amount in which the active ingredient methyl paraoxybenzoate exhibits an antibacterial effect against Corynebacterium, and in this range Although not particularly limited, specifically, the amount of methyl paraoxybenzoate in the external composition exceeds about 0.1% by weight, preferably about 0.15% by weight or more, more preferably 0.2% by weight. It is desirable that it be included within a range of more than about.

本発明は、かくして調製される外用組成物をも提供するものである。該外用組成物は、腋臭を防止する目的で、医薬品、医薬部外品及び化粧料(香粧料)の分野において広く用いることができる。その形態も特に制限されることなくクリーム、軟膏、ローション、スプレー、エアゾール、乳液、フォーム、洗浄料、石鹸、浴用剤、スキンコンディショナー、化粧水、パック剤、ファンデーション並びに上記抗菌剤をシート状基材に含浸させたシート剤、貼付剤またはパップ剤、ロールオン剤等の使用形態に合わせて液状、半固形状、気泡状及び固形状に適宜調製される。  The present invention also provides a composition for external use thus prepared. The composition for external use can be widely used in the fields of pharmaceuticals, quasi-drugs, and cosmetics (cosmetics) for the purpose of preventing odor. The form is not particularly limited, and cream, ointment, lotion, spray, aerosol, emulsion, foam, cleaning agent, soap, bath preparation, skin conditioner, lotion, pack agent, foundation and the above antibacterial agent are formed into a sheet-like base material. According to usage forms such as a sheet agent, a patch or a poultice, a roll-on agent, etc. impregnated into a liquid, it is appropriately prepared in a liquid, semi-solid, bubble and solid form.

該外用組成物は、パラオキシ安息香酸メチルを有効成分とする上記抗菌剤に加えて、各種形態に応じて、一般的に外用組成物に配合される担体;防腐剤、保存剤、安定剤、沈殿防止剤、pH調整剤、香料、界面活性剤(アニオン性、カチオン性、ノニオン性、両性界面活性剤)、着色剤、清澄剤、粘度調整剤、殺菌抗菌剤、精油等の各種添加剤を配合することができる。かかる担体並びに添加剤としては、人体に安全なものが好ましく、より好ましくは皮膚等に対して刺激性のないものである。  In addition to the above-mentioned antibacterial agent containing methyl paraoxybenzoate as an active ingredient, the composition for external use generally comprises a carrier generally incorporated in the composition for external use according to various forms; an antiseptic, a preservative, a stabilizer, a precipitate Contains various additives such as inhibitors, pH adjusters, fragrances, surfactants (anionic, cationic, nonionic, amphoteric surfactants), colorants, refining agents, viscosity modifiers, bactericidal antibacterial agents, and essential oils. can do. Such carriers and additives are preferably those that are safe for the human body, and more preferably those that are not irritating to the skin or the like.

担体としては、例えば液状形態の場合は、水(例えばイオン交換水)、アルコール(例えばエタノール)、並びに水溶性溶剤(例えばプロピレングリコールやグリセリン等)などを、また固体形態の場合は各種のゲル化剤(例えば、カラギーナンやアルギン酸ナトリウム等の海藻多糖類;グアーガムやタマリンドシードガム等の種子多糖類;アラビアガムやトラガントガムなどの植物樹液多糖類;キサンタンガムやジェランガム等の発酵多糖類;ゼラチン等の蛋白質;カルボキシメチルセルロース等のセルロース誘導体等);タルクやシリカ等の無機材;ポリアクリル酸ナトリウム等のポリアクリル酸類などをあげることができる。  Examples of the carrier include water (for example, ion-exchanged water), alcohol (for example, ethanol), and a water-soluble solvent (for example, propylene glycol and glycerin) in the case of a liquid form, and various gellings in the case of a solid form. Agents (for example, seaweed polysaccharides such as carrageenan and sodium alginate; seed polysaccharides such as guar gum and tamarind seed gum; plant sap polysaccharides such as gum arabic and tragacanth gum; fermentation polysaccharides such as xanthan gum and gellan gum; proteins such as gelatin; And cellulose derivatives such as carboxymethyl cellulose); inorganic materials such as talc and silica; and polyacrylic acids such as sodium polyacrylate.

防腐剤としては、安息香酸、ソルビン酸、プロピオン酸、デヒドロ酢酸、サリチル酸、エデト酸及びそれら塩;亜硫酸ナトリウム、次亜硫酸ナトリウム、ピロ亜硫酸ナトリウム等の無機塩類;ペクチン抽出物などの植物由来成分などを例示することができる。  Examples of preservatives include benzoic acid, sorbic acid, propionic acid, dehydroacetic acid, salicylic acid, edetic acid and their salts; inorganic salts such as sodium sulfite, sodium hyposulfite and sodium pyrosulfite; plant-derived components such as pectin extract It can be illustrated.

沈殿防止剤としては、二酸化ケイ素、ステアリン酸マグネシウム等の微粒子粉体、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンソルビタンモノステアレート等の界面活性剤及びキサンタンガム、ポリエチレングリコール等のゲル化剤等を例示することができる。  Examples of suspending agents include fine particle powders such as silicon dioxide and magnesium stearate, surfactants such as polyoxyethylene hydrogenated castor oil and polyoxyethylene sorbitan monostearate, and gelling agents such as xanthan gum and polyethylene glycol. can do.

pH調整剤としては、クエン酸、フマル酸、DL−リンゴ酸並びにその塩類;炭酸水素ナトリウム、炭酸カリウムなどの炭酸塩類;リン酸、リン酸二水素ナトリウム等のリン酸塩などを例示することができる。  Examples of the pH adjuster include citric acid, fumaric acid, DL-malic acid and salts thereof; carbonates such as sodium hydrogen carbonate and potassium carbonate; phosphates such as phosphoric acid and sodium dihydrogen phosphate; it can.

前述する各種の成分は単に一例を記載したに過ぎず、本発明はこれらの成分に何ら限定されることはない。すなわち本発明の皮膚外用剤には、他の添加成分も含めて、通常外用剤の成分として使用される各種の成分が使用できる。  The various components described above are merely examples, and the present invention is not limited to these components. That is, in the external preparation for skin of the present invention, various components that are usually used as components for external preparations can be used, including other additive components.

本発明の外用組成物、特に腋臭防止用の外用組成物は、コリネバクテリウム属菌、特に腋臭の発生の原因となる腋臭菌に対する殺菌作用に基づいて、腋臭や汗臭の発生を防止する効果に優れている。従って、該外用組成物は、別の観点から腋臭や汗臭の発生を抑制するために使用される防臭剤(防体臭剤)、特に防腋臭剤として位置づけることもできる。  The composition for external use of the present invention, especially the composition for external use for preventing odor, is an effect of preventing the generation of odor and sweat odor based on the bactericidal action against Corynebacterium, particularly the odor bacterium causing the generation of odor. Is excellent. Therefore, the composition for external use can be positioned as a deodorant (anti-body odorant) used for suppressing the generation of a foul odor or sweat odor from another viewpoint, particularly as a deodorant.

さらに本発明の外用組成物は、コリネバクテリウム属菌が存在する皮膚(皮表)に直接塗布する使用態様のほか、スプレーやエアゾールなどの形態や洗濯仕上げ剤やコーティング剤などの形態に調製することによってコリネバクテリウム属菌が付着した(または付着する可能性のある)下着やシャツ等の衣類に噴霧、浸漬またはコーティングする使用態様で用いることができる。  Furthermore, the composition for external use of the present invention is prepared in a form such as a spray or aerosol, a laundry finish or a coating agent in addition to a use form directly applied to the skin (skin surface) where Corynebacterium is present. Thus, it can be used in a use mode in which spraying, dipping or coating is applied to clothing such as underwear or shirt to which Corynebacterium is attached (or possibly attached).

また本発明の防臭剤(防体臭剤、防腋臭剤)には、本発明の効果を妨げないことを限度として、上記その他の抗菌成分に加えて、衣類用のスプレー剤やエアゾール剤等に配合される公知の防腐剤、保存剤、安定剤、沈殿防止剤、pH調整剤、香料、界面活性剤(アニオン性、カチオン性、ノニオン性、両性界面活性剤)、清澄剤、粘度調整剤、殺菌抗菌剤等の各種添加剤を配合することができる。かかる担体並びに添加剤としては、人体に安全なものが好ましく、より好ましくは皮膚等に対して刺激性のないものである。  In addition to the above-mentioned other antibacterial components, the deodorant of the present invention (anti-body deodorant, anti-deodorant) is blended in clothing sprays, aerosols, etc. in addition to the above antibacterial components. Known preservatives, preservatives, stabilizers, precipitation inhibitors, pH adjusters, fragrances, surfactants (anionic, cationic, nonionic, amphoteric surfactants), clarifiers, viscosity modifiers, bactericides Various additives such as antibacterial agents can be blended. Such carriers and additives are preferably those that are safe for the human body, and more preferably those that are not irritating to the skin or the like.

本発明によれば、コリネバクテリウム属菌に対して優れた抗菌作用を有する抗菌剤、及び該抗菌剤を含有する外用組成物を提供することができる。さらに、該抗菌剤に低揮発性、低皮膚浸透性であるプロピレングリコールを配合することにより、長く皮膚上に滞留させることで、長時間にわたって抗菌効果を発揮できる抗菌剤及び該抗菌剤を含有する外用組成物を提供することができる。  According to the present invention, it is possible to provide an antibacterial agent having an excellent antibacterial action against Corynebacterium, and an external composition containing the antibacterial agent. Furthermore, by containing propylene glycol having low volatility and low skin permeability in the antibacterial agent, the antibacterial agent capable of exerting an antibacterial effect for a long time by containing on the skin for a long time and the antibacterial agent are contained. An external composition can be provided.

以下、実施例及び処方例をあげて本発明を具体的に説明するが、本発明はこれらの実施例に何ら限定されるものではない。  EXAMPLES Hereinafter, although an Example and a formulation example are given and this invention is demonstrated concretely, this invention is not limited to these Examples at all.

試験方法
ペーパーディスク法による阻止円径の測定により抗菌力を評価した。
Test method Antibacterial activity was evaluated by measuring the inhibition circle diameter by the paper disk method.

コリネバクテリウム ミヌティシマムを、トリプチケースソイ寒天培地に塗布し、35℃にて24時間、増菌させた後、減菌生理食塩水にMacfaland0.5になるように懸濁させた。  Corynebacterium minutishimam was applied to trypticase soy agar medium, and the cells were enriched at 35 ° C. for 24 hours, and then suspended in sterilized physiological saline to have Macfarand 0.5.

シャーレ中のトリプチケースソイ寒天培地上に、この懸濁液50μLをコンラージ棒で均一に塗布し、その上にペーパーディスク(直径8mm)を置いて試料(パラオキシ安息香酸メチル、パラオキシ安息香酸エチル又はパラオキシ安息香酸プロピル)50μLを含浸させた。これを35℃にて24時間培養後、阻止円の有無とその直径を測定した。  Apply 50 μL of this suspension uniformly on a trypticase soy agar medium in a petri dish with a conical rod, and place a paper disk (diameter 8 mm) on the sample (methyl paraoxybenzoate, ethyl paraoxybenzoate or 50 μL of propyl paraoxybenzoate) was impregnated. After incubation at 35 ° C. for 24 hours, the presence or absence of a blocking circle and its diameter were measured.

試験結果
0.2重量%のパラオキシ安息香酸メチルでは、阻止円形成が見られたが、それ以外の濃度では阻止円形成は見られなかった。また、パラオキシ安息香酸エチル及びパラオキシ安息香酸プロピルにおいては、0.01重量%、0.1重量%又は0.2重量%のいずれの濃度においても阻止円形成は見られなかった。
Test results In 0.2% by weight of methyl paraoxybenzoate, inhibition circle formation was observed, but no inhibition circle formation was observed at other concentrations. Further, in the case of ethyl paraoxybenzoate and propyl paraoxybenzoate, no inhibition circle formation was observed at any concentration of 0.01% by weight, 0.1% by weight or 0.2% by weight.

従って、0.2重量%のパラオキシ安息香酸メチルにコリネバクテリウム ミヌティシマムに対して抗菌作用があることがわかった。  Therefore, it was found that 0.2% by weight of methyl paraoxybenzoate has an antibacterial action against Corynebacterium minutisimam.

パラオキシ安息香酸メチル、パラオキシ安息香酸エチル又はパラオキシ安息香酸プロピルを0.01重量%、0.1重量%又は0.2重量%用いた場合、及びプロピレングリコールを5重量%、10重量%又は20重量%用いた場合のペーパーディスク法による測定結果を表1に示す。  When 0.01%, 0.1%, or 0.2% by weight of methyl paraoxybenzoate, ethyl paraoxybenzoate, or propyl paraoxybenzoate is used, and 5% by weight, 10% by weight, or 20% by weight of propylene glycol Table 1 shows the results of measurement by the paper disk method when% is used.

Figure 2005289953
表2は、パラオキシ安息香酸メチルとプロピレングリコールを併用した場合のペーパーディスク法による測定結果を示す。
Figure 2005289953
Table 2 shows the measurement results by the paper disk method when methyl paraoxybenzoate and propylene glycol are used in combination.

Figure 2005289953
表3は、パラオキシ安息香酸エチルとプロピレングリコールを併用した場合のペーパーディスク法による測定結果を示す。
Figure 2005289953
Table 3 shows the measurement results by the paper disk method when ethyl paraoxybenzoate and propylene glycol are used in combination.

Figure 2005289953
表4は、パラオキシ安息香酸プロピルとプロピレングリコールを併用した場合のペーパーディスク法による測定結果を示す。
Figure 2005289953
Table 4 shows the measurement results by the paper disk method when propyl paraoxybenzoate and propylene glycol are used in combination.

Figure 2005289953
Figure 2005289953

以下、パラオキシ安息香酸メチルを用いた製剤の処方例を示すが、本発明はこれに限定されるものではない。  Hereinafter, although the formulation example of the formulation using methyl paraoxybenzoate is shown, this invention is not limited to this.

[処方例1]
[g]
軟膏 パラオキシ安息香酸メチル 0.2
グリチルリチン酸ジカリウム 0.5
ベントナイト 25
カオリン 25
グリセリン 15
プロピレングリコール 10
精製水 24.3
合計 100
[Prescription Example 1]
[G]
Ointment Methyl paraoxybenzoate 0.2
Dipotassium glycyrrhizinate 0.5
Bentonite 25
Kaolin 25
Glycerin 15
Propylene glycol 10
Purified water 24.3
Total 100

[処方例2]
液剤 [g]
ポリオキシエチレンオレイルエーテル1
エタノール 10
パラオキシ安息香酸メチル 0.2
精製水 88.8
合計 100
[Prescription Example 2]
Liquid [g]
Polyoxyethylene oleyl ether 1
Ethanol 10
Methyl paraoxybenzoate 0.2
Purified water 88.8
Total 100

[処方例3]
エアゾール [g]
プロピレングリコール 20
パラオキシ安息香酸メチル 0.2
イソプロピルメチルフェーノール0.1
精製水 24.9
液化石油ガス 50
合計 100
[Prescription Example 3]
Aerosol [g]
Propylene glycol 20
Methyl paraoxybenzoate 0.2
Isopropyl methylphenol 0.1
Purified water 24.9
Liquefied petroleum gas 50
Total 100

Claims (7)

パラオキシ安息香酸メチルを有効成分とするコリネバクテリウム属菌に対する抗菌剤。  Antibacterial agent against Corynebacterium spp. Containing methyl paraoxybenzoate as an active ingredient. コリネバクテリウム属菌が、コリネバクテリウム キセロシス、コリネバクテリウムミヌティシマム又はコリネバクテリウム テヌイスである請求項1に記載の抗菌剤。  The antibacterial agent according to claim 1, wherein the Corynebacterium is Corynebacterium xerosis, Corynebacterium minutishima or Corynebacterium tenuis. パラオキシ安息香酸メチルを0.2重量%以上含有する請求項1又は2のいずれかに記載の抗菌剤。  The antibacterial agent in any one of Claim 1 or 2 containing 0.2 weight% or more of methyl paraoxybenzoates. さらに皮膚滞留剤を含有する請求項1〜3のいずれかに記載の抗菌剤。  Furthermore, the antibacterial agent in any one of Claims 1-3 containing a skin retention agent. 該皮膚滞留剤が、プロピレングリコールである請求項4に記載の抗菌剤。  The antibacterial agent according to claim 4, wherein the skin retention agent is propylene glycol. 請求項1〜5のいずれかに記載の抗菌剤を含有する外用組成物。  The composition for external use containing the antibacterial agent in any one of Claims 1-5. 腋臭防止用である請求項6に記載の外用組成物。  The composition for external use according to claim 6, which is used for preventing odor.
JP2004134805A 2004-03-31 2004-03-31 ANTIBACTERIAL AGENT COMPRISING METHYL p-HYDROXYBENZOATE AS ACTIVE INGREDIENT AND EXTERNAL COMPOSITION COMPRISING THE SAME Pending JP2005289953A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2004134805A JP2005289953A (en) 2004-03-31 2004-03-31 ANTIBACTERIAL AGENT COMPRISING METHYL p-HYDROXYBENZOATE AS ACTIVE INGREDIENT AND EXTERNAL COMPOSITION COMPRISING THE SAME
PCT/JP2004/013899 WO2005099683A1 (en) 2004-03-31 2004-09-24 Antibacterial agent whose active ingredint is methyl paraoxybenzoate and composition for external application containing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004134805A JP2005289953A (en) 2004-03-31 2004-03-31 ANTIBACTERIAL AGENT COMPRISING METHYL p-HYDROXYBENZOATE AS ACTIVE INGREDIENT AND EXTERNAL COMPOSITION COMPRISING THE SAME

Publications (1)

Publication Number Publication Date
JP2005289953A true JP2005289953A (en) 2005-10-20

Family

ID=35149751

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004134805A Pending JP2005289953A (en) 2004-03-31 2004-03-31 ANTIBACTERIAL AGENT COMPRISING METHYL p-HYDROXYBENZOATE AS ACTIVE INGREDIENT AND EXTERNAL COMPOSITION COMPRISING THE SAME

Country Status (2)

Country Link
JP (1) JP2005289953A (en)
WO (1) WO2005099683A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002255711A (en) * 2001-02-28 2002-09-11 Kobayashi Pharmaceut Co Ltd Antibacterial composition
JP2002325828A (en) * 2001-05-02 2002-11-12 Ikeda Shokken Kk Deodorant and use thereof
JP2003321347A (en) * 2002-05-07 2003-11-11 Rohto Pharmaceut Co Ltd Gel ointment
JP2003335704A (en) * 2002-05-17 2003-11-28 Xantech Pharmaceuticals Inc Composite composition of antisudorific and antibacterial agent
JP2005239705A (en) * 2004-02-27 2005-09-08 Stiefel Lab Inc Local antibacterial preparation

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002255711A (en) * 2001-02-28 2002-09-11 Kobayashi Pharmaceut Co Ltd Antibacterial composition
JP2002325828A (en) * 2001-05-02 2002-11-12 Ikeda Shokken Kk Deodorant and use thereof
JP2003321347A (en) * 2002-05-07 2003-11-11 Rohto Pharmaceut Co Ltd Gel ointment
JP2003335704A (en) * 2002-05-17 2003-11-28 Xantech Pharmaceuticals Inc Composite composition of antisudorific and antibacterial agent
JP2005239705A (en) * 2004-02-27 2005-09-08 Stiefel Lab Inc Local antibacterial preparation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
桝渕 幸吉, 最近の皮膚外用剤, vol. 第1版, JPN6010040912, 1991, pages 160 - 166, ISSN: 0001679305 *

Also Published As

Publication number Publication date
WO2005099683A1 (en) 2005-10-27

Similar Documents

Publication Publication Date Title
CA1202243A (en) Deodorant compound
JP3529093B2 (en) Combinations of compounds with bactericidal activity
JP2008110999A (en) Antibacterial composition and deodorant agent
US20030215472A1 (en) Methods and compositions employing a dialkyl amide
JPH0892011A (en) Deodorizing make-up goods
PT87807B (en) PROCESS FOR THE PREPARATION OF DEODORIZING AND ANTIMICROBIAL COMPOSITIONS FOR USE IN COSMETIC OR TOPIC FORMULATIONS
JPH0753344A (en) Deodorizing activity compound combinated substance based on alpha. and omega. - alkanedicarboxylic acid and wool wax acid
JPH0826957A (en) Compounding agent of deodorizing active compound based on alpha, omega-alkane dicarboxylic acid and oligoglycerol monocarboxylate ester
JPWO2015146398A1 (en) Deodorant composition and deodorant agent
JPS61243010A (en) Cosmetic containing epsilon-polylysine and hydrochloride thereof as preservative and germicide incorporated therein
JP4565275B2 (en) Antibacterial composition
JP6474963B2 (en) Cleaning composition
JP4666938B2 (en) Plant antibacterial composition
CA2318932C (en) Deodorant composition containing d-amino acid
JP4743704B2 (en) Antibacterial agent for bad odor bacteria, anti-odor agent and external preparation for skin containing the antibacterial agent
JP2007145771A (en) Antibacterial agent composition and deodorant agent
EP2872220B1 (en) Deodorant methods
JP2018521099A (en) Cosmetic formulations that reduce sweat
JP2005289953A (en) ANTIBACTERIAL AGENT COMPRISING METHYL p-HYDROXYBENZOATE AS ACTIVE INGREDIENT AND EXTERNAL COMPOSITION COMPRISING THE SAME
JP2019081763A (en) Cleaning composition
JP5025535B2 (en) Antibacterial agent composition and deodorant composition
BR112017013208B1 (en) use of octenidine dihydrochloride
JP5586130B2 (en) Antibacterial composition and cosmetics
JP2006096719A (en) Deodorizing composition and deodorant preparation
JP5393962B2 (en) Antibacterial agent for odor-causing bacteria and anti-odor agent containing the antibacterial agent

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070315

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100728

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20101207